Immediate Impact
1 from Science/Nature 52 standout
Citing Papers
Translating p53-based therapies for cancer into the clinic
2024 Standout
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
2024 Standout
Works of Els Lierman being referenced
The ability of sorafenib to inhibit oncogenic PDGFR and FLT3 mutants and overcome resistance to other small molecule inhibitors
2007
Sorafenib is a potent inhibitor of FIP1L1-PDGFRα and the imatinib-resistant FIP1L1-PDGFRα T674I mutant
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Els Lierman | 189 | 204 | 154 | 154 | 19 | 448 | |
| Bernadette Guerton | 186 | 104 | 163 | 117 | 13 | 419 | |
| Linda M. Bavisotto | 126 | 122 | 101 | 170 | 18 | 394 | |
| Hideo Hyodo | 296 | 66 | 211 | 212 | 17 | 503 | |
| Benjamin Hébraud | 186 | 165 | 82 | 212 | 24 | 495 | |
| Ayumi Okuyama | 45 | 202 | 98 | 95 | 22 | 435 | |
| Feiyan Wang | 136 | 43 | 137 | 135 | 27 | 384 | |
| Alessia Moro | 200 | 107 | 253 | 177 | 17 | 406 | |
| N. Rinaldi | 54 | 213 | 37 | 73 | 16 | 456 | |
| M Shtalrid | 308 | 81 | 214 | 67 | 28 | 459 | |
| Marjan Daneshpouy | 142 | 70 | 53 | 99 | 12 | 499 |
All Works
Loading papers...